Pennymac Mortgage Investment Trust’s filing revealed that its Director Lynch Catherine A. acquired Company’s shares for reported $16954.0 on Jul 25 ’25. In the deal valued at $12.41 per share,1,366 shares were bought. As a result of this transaction, Lynch Catherine A. now holds 51,888 shares worth roughly $0.63 million.
Then, Lynch Catherine A. bought 2,878 shares, generating $34,968 in total proceeds. Upon buying the shares at $12.15, the Director now owns 49,254 shares.
Before that, Lynch Catherine A. bought 1,268 shares. Pennymac Mortgage Investment Trust shares valued at $15,298 were divested by the Director at a price of $12.06 per share. As a result of the transaction, Lynch Catherine A. now holds 50,522 shares, worth roughly $0.61 million.
A number of analysts have revised their coverage, including Keefe Bruyette’s analysts, who decreased its forecast for the stock in late July from “an Outperform” to “a Mkt perform”. Keefe Bruyette also remained covering PMT and has increased its forecast on July 10, 2024 with a “an Outperform” recommendation from previously “Mkt perform” rating. Deutsche Bank started covering the stock on January 10, 2024. It rated PMT as “a Hold”.
Price Performance Review of PMT
On Tuesday, Pennymac Mortgage Investment Trust [NYSE:PMT] saw its stock fall -0.82% to $12.15. Over the last five days, the stock has lost -1.94%. Pennymac Mortgage Investment Trust shares have fallen nearly -12.72% since the year began. Nevertheless, the stocks have fallen -3.49% over the past one year.
How much short interest is there in Pennymac Mortgage Investment Trust?
A steep rise in short interest was recorded in Pennymac Mortgage Investment Trust stocks on 2025-08-29, growing by 0.12 million shares to a total of 4.27 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 4.15 million shares. There was a rise of 2.83%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 06, 2023 when UBS began covering the stock and recommended ‘”a Neutral”‘ rating along with a $13.50 price target.
